Skip to Content

Join the 'Pain Relief' group to help and get support from people like you.

Pain Relief News

Collegium Receives FDA Approval for Xtampza ER, an Analgesic with Abuse-Deterrent Properties

Posted 30 Apr 2016 by Drugs.com

CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) – Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza ER (oxycodone) extended-release (ER) capsules CII, a twice-daily, oxycodone medication for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative ...

Ask a Question